Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy “The COMBO – DN” (Combination vs Monotherapy of Pregabalin and duloxetine in Diabetic Neuropathy).
Year: 2012
Type: Pharmaceutical - Pain
Phase: IIIb
Indication: Painful Diabetic Neuropathy
A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate improvement in symptoms of constipation and noninferiority in analgesic efficacy in subjects with non-malignant or malignant pain that requires around-the-clock opioid therapy taking 50/25 – 80/40 mg twice daily as oxycodone/naloxone prolonged release (OXN PR) tablets compared to subjects taking 50 – 80 mg twice daily oxycodone prolonged release (OxyPR) tablets alone.
Year: 2012
Type: Pharmaceutical - Pain
Phase: III
Indication: Pain - General
A Multi-Centre, Randomised, Double-Blinded, Placebo Controlled, Parallel Group, Multiple Dose Study of the Efficacy of 8.75mg Flurbiprofen Spray in the Relief of Sore Throat due to URTI.
Year: 2012
Type: Pharmaceutical - Other
Phase: III
Indication: Other
An Open-label Historically Controlled Study to Assess the Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects with Multiple Dupuytren’s Contractures with Palpable Cords.
Year: 2012
Type: Musculoskeletal
Phase: IIIb
Indication: Other
A Prospective Trial to Assess the Safety and Performance of the Spinal Modulation Neurostimulator System in the Treatment of Chronic Pain.
Year: 2012
Type: Device
Phase: N/A
Indication: Chronic Trunk and/or Limb Pain
Precision High-Rate Sub-perception Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain.
Year: 2012
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain
A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.
Year: 2012
Type: Musculoskeletal
Phase: II
Indication: Knee Osteoarthritis
Partnership for Advancement in Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry.
